<DOC>
	<DOCNO>NCT00884897</DOCNO>
	<brief_summary>Objective : Social Cognition Emotional Intelligence show deficient patient schizophrenia remediate antipsychotic medication psychosocial intervention . Social cognition associate functional outcome , important step strive recovery population . The hormone neurotransmitter , oxytocin , associate social bonding trust show improve measure aspects social cognition human . The study assess effect acute administration intranasal oxytocin measure social cognition function well emotional intelligence symptom . Study population : The study population include patient DSM-IV diagnosis schizophrenia schizoaffective disorder stable medication regimen 6 week . We enroll total 30 subject ( N=15 placebo N=15 oxytocin group ) . Experimental design method : After one week lead phase , participant undergo 3 week oxytocin ( 20 IU BID ) placebo administration ( double blind ) addition exist medication regimen . Outcome measure administer lead phase , end study drug administration phase ( acute effect OT ) . The primary outcome measure Mayer-Salovey-Caruso Emotional Intelligence Test ( MSCEIT ) Maryland Assessment Social Competence ( MASC ) . Secondary measure include rating domain social cognition ( emotion perception , attributional style , theory mind social perception ) , symptom rating measure social anxiety quality life . Side effect symptom measure weekly .</brief_summary>
	<brief_title>Oxytocin Social Cognition Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Oxytocin</mesh_term>
	<criteria>Inclusion criterion : All participant must : 1 . Be age 18 55 . 2 . Meet DSMIV criterion Schizophrenia Schizoaffective Disorder . 3 . Treated stabilized antipsychotic regimen ( i.e. , change antipsychotic medication previous six week change dose past 30 day ) . Exclusion criterion : Participants exclude evidence : 1 . DSMIV criterion substance dependence last 6 month DSMIV criterion abuse past 30 day . 2 . Cognitive impairment severe enough preclude informed consent valid response questionnaire . This define score less 10 Evaluation Sign Consent ( ESC ) judge treat clinician . 3 . Medical illness view investigator would compromise participation research . 4 . History polydipsia and/or hyponatremia 5 . Clinically significant endocrine disorder , judge PI . Abnormalities prolactin level thyroid function test associate use dopamine antagonist medication exclusionary . 6 . Pregnancy , plan become pregnant , breastfeed . In addition , woman childbearing age require use effective form birth control duration study . Effective form birth control include : hormonal contraceptive ( birth control pill , injectable hormone , vaginal ring hormone ) , surgical sterility ( tubal ligation hysterectomy ) IUD Diaphragm spermicide Condom spermicide Abstinence 7 . Use drug ( prostaglandin , vasoconstricting agent anesthetic medication , example ) may interact oxytocin . Justification : Avoidance adverse interaction oxytocin . Assessment tool ( ) : Clinical interview toxicology screen 8 . History hypersensitivity oxytocin vehicle , i.e . propyl parahydroxybenzoate , methyl parahydroxybenzoate , chlorobutanol hemihydrate . Assessment tool : clinical interview 9 . Presence history clinically significant allergic rhinitis assess PI , M.D. , Nurse . Justification : Inflammation nasal mucosa could interfere mucosal absorption intranasally administer OT . Current rhinitis upper respiratory infection resolve prior enrollment study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Social Cognition</keyword>
	<keyword>Schizophrenia</keyword>
	<keyword>Oxytocin</keyword>
</DOC>